Edition:
United States

Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

68.42USD
20 Sep 2018
Change (% chg)

$-0.33 (-0.48%)
Prev Close
$68.75
Open
$68.99
Day's High
$70.22
Day's Low
$67.93
Volume
94,862
Avg. Vol
106,281
52-wk High
$70.22
52-wk Low
$26.54

Chart for

About

Genomic Health, Inc. is a healthcare company that provides genomic-based diagnostic tests to personalize cancer treatment. The Company develops and commercializes genomic-based clinical laboratory services. The Company's Oncotype IQ Genomic Intelligence Platform is consisted of its flagship line of Oncotype DX gene expression... (more)

Overall

Beta: 0.46
Market Cap(Mil.): $2,465.05
Shares Outstanding(Mil.): 35.86
Dividend: --
Yield (%): --

Financials

  GHDX.OQ Industry Sector
P/E (TTM): 625.11 107.68 32.65
EPS (TTM): 0.11 -- --
ROI: 2.10 1.61 12.72
ROE: 2.14 0.32 14.84

BRIEF-New Data Reinforce Positive Impact Of The Oncotype Dx Genomic Prostate Score Test In Guiding Treatment Decisions

* NEW DATA REINFORCE POSITIVE IMPACT OF THE ONCOTYPE DX® GENOMIC PROSTATE SCORE™ TEST IN GUIDING TREATMENT DECISIONS Source text for Eikon: Further company coverage:

May 21 2018

BRIEF-Genomic Health Q1 Loss Per Share $0.11

* GENOMIC HEALTH ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND REPORTS RECENT BUSINESS PROGRESS

May 02 2018

Earnings vs. Estimates